| Characteristics . | Patient values . |
|---|---|
| Age (years) | 64 (24–89) |
| Sex (male/female) | 25/23 |
| BMI (kg/m2) | 26 (17–55) |
| Serum creatinine (μmol/L) | 98 (39–220) |
| 8 h CLCR (mL/min) | 67 (7–204) |
| Serum albumin (g/L) | 19 (11–34) |
| Fluid balance in ICU (mL) | +12 (−4349 to 16 380) |
| Fluid balance in the last 24 h (mL) | +964 (−3352 to 5040) |
| Days of treatment before sampling | 1.3 (0–10) |
| Origin of sepsis, n (%) | |
| lung | 13 (27) |
| abdomen | 9 (19) |
| urinary tract | 0 |
| soft tissue | 19 (40) |
| other | 7 (15) |
| APACHE II score (at admission) | 26 (10–41) |
| SAPS II | 49 (22–87) |
| SOFA score (at day of inclusion) | 8 (5–14) |
| Survival (% at 90 days) | 67 |
| Characteristics . | Patient values . |
|---|---|
| Age (years) | 64 (24–89) |
| Sex (male/female) | 25/23 |
| BMI (kg/m2) | 26 (17–55) |
| Serum creatinine (μmol/L) | 98 (39–220) |
| 8 h CLCR (mL/min) | 67 (7–204) |
| Serum albumin (g/L) | 19 (11–34) |
| Fluid balance in ICU (mL) | +12 (−4349 to 16 380) |
| Fluid balance in the last 24 h (mL) | +964 (−3352 to 5040) |
| Days of treatment before sampling | 1.3 (0–10) |
| Origin of sepsis, n (%) | |
| lung | 13 (27) |
| abdomen | 9 (19) |
| urinary tract | 0 |
| soft tissue | 19 (40) |
| other | 7 (15) |
| APACHE II score (at admission) | 26 (10–41) |
| SAPS II | 49 (22–87) |
| SOFA score (at day of inclusion) | 8 (5–14) |
| Survival (% at 90 days) | 67 |
Data presented are median (range) or number of patients.
| Characteristics . | Patient values . |
|---|---|
| Age (years) | 64 (24–89) |
| Sex (male/female) | 25/23 |
| BMI (kg/m2) | 26 (17–55) |
| Serum creatinine (μmol/L) | 98 (39–220) |
| 8 h CLCR (mL/min) | 67 (7–204) |
| Serum albumin (g/L) | 19 (11–34) |
| Fluid balance in ICU (mL) | +12 (−4349 to 16 380) |
| Fluid balance in the last 24 h (mL) | +964 (−3352 to 5040) |
| Days of treatment before sampling | 1.3 (0–10) |
| Origin of sepsis, n (%) | |
| lung | 13 (27) |
| abdomen | 9 (19) |
| urinary tract | 0 |
| soft tissue | 19 (40) |
| other | 7 (15) |
| APACHE II score (at admission) | 26 (10–41) |
| SAPS II | 49 (22–87) |
| SOFA score (at day of inclusion) | 8 (5–14) |
| Survival (% at 90 days) | 67 |
| Characteristics . | Patient values . |
|---|---|
| Age (years) | 64 (24–89) |
| Sex (male/female) | 25/23 |
| BMI (kg/m2) | 26 (17–55) |
| Serum creatinine (μmol/L) | 98 (39–220) |
| 8 h CLCR (mL/min) | 67 (7–204) |
| Serum albumin (g/L) | 19 (11–34) |
| Fluid balance in ICU (mL) | +12 (−4349 to 16 380) |
| Fluid balance in the last 24 h (mL) | +964 (−3352 to 5040) |
| Days of treatment before sampling | 1.3 (0–10) |
| Origin of sepsis, n (%) | |
| lung | 13 (27) |
| abdomen | 9 (19) |
| urinary tract | 0 |
| soft tissue | 19 (40) |
| other | 7 (15) |
| APACHE II score (at admission) | 26 (10–41) |
| SAPS II | 49 (22–87) |
| SOFA score (at day of inclusion) | 8 (5–14) |
| Survival (% at 90 days) | 67 |
Data presented are median (range) or number of patients.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
